Maria I. Passalacqua

Messina, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience.

Feasibility and safety of recombinant zoster vaccination in patients undergoing active cancer treatments: A real-world single-center experience.

Journal: Human vaccines & immunotherapeutics

Published: July 30, 2026

Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies.

Impact of Proton Pump Inhibitor Use on Progression-Free and Overall Survival in Cancer Patients Undergoing Immune Checkpoint Inhibitor Therapy: A Systematic Review and Meta-Analysis of Recent Studies.

Journal: Cancers

Published: May 20, 2025

Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives.

Therapeutic strategies for HER2-positive breast cancer with central nervous system involvement: a literature review and future perspectives.

Journal: Translational cancer research

Published: July 03, 2023

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.

Immunotherapy in Early-Stage Non-Small Cell Lung Cancer (NSCLC): Current Evidence and Perspectives.

Journal: Current oncology (Toronto, Ont.)

Published: March 05, 2023

Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.

Enfortumab Vedotin in metastatic bladder cancer: a case report of durable clinical efficacy in a pretreated patient.

Journal: Acta bio-medica : Atenei Parmensis

Published: December 26, 2022

'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research'.

'Why is survival with triple negative breast cancer so low? insights and talking points from preclinical and clinical research'.

Journal: Expert opinion on investigational drugs

Published: December 15, 2022

Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives.

Evolving treatment landscape of immunotherapy in breast cancer: current issues and future perspectives.

Journal: Therapeutic advances in medical oncology

Published: September 06, 2022

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Targeted therapies for KRAS-mutant non-small cell lung cancer: from preclinical studies to clinical development-a narrative review.

Journal: Translational lung cancer research

Published: September 03, 2022

Immunotherapeutic Advances for NSCLC.

Immunotherapeutic Advances for NSCLC.

Journal: Biologics : targets & therapy

Published: June 19, 2021

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer.

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer.

Journal: Urology case reports

Published: September 15, 2020

Showing 1-10 of 10

Last Updated: 09/26/2026